Overview

Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)

Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long term safety and efficacy in subjects with Type 1 Diabetes Mellitus who completed the Protege Study (CP-MGA031-01).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
MacroGenics
Collaborator:
Eli Lilly and Company
Treatments:
Antibodies, Monoclonal